Report cover image

Global Beta-Nicotinamide Mononucleotide (NMN) Market Insights, Forecast to 2028

Publisher QYResearch Group
Published Jun 01, 2022
Length 141 Pages
SKU # QYR17266349

Description

Global Beta-Nicotinamide Mononucleotide (NMN) Market Insights, Forecast to 2028

Market Analysis and Insights: Global Beta-Nicotinamide Mononucleotide (NMN) Market
The global Beta-Nicotinamide Mononucleotide (NMN) market is valued at US$ 256.74 million in 2021. The market size will reach US$ 1075.42 million by the end of 2028, growing at a CAGR of 20.23% during 2022-2028.
Global Beta-Nicotinamide Mononucleotide (NMN) Scope and Segment
Beta-Nicotinamide Mononucleotide (NMN) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Beta-Nicotinamide Mononucleotide (NMN) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.

By Company
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway

Segment by Type
Content ＜98%
Content ≥98%

Segment by Application
Health Care Products
Cosmetics
Others

Segment by Region
North America
U.S.
Canada

Asia-Pacific
China
Japan
Korea
India
Australia
Southeast Asia

Europe
Germany
France
U.K.
Italy
Russia

Latin America
Mexico
Brazil
Argentina

Middle East and Africa
Middle East
Africa

Table of Contents

141 Pages
1 Study Coverage
1.1 Beta-nicotinamide Mononucleotide (Nmn) Product Introduction
1.2 Market By Type
1.3 Market By Application
1.3.1 Global Beta-nicotinamide Mononucleotide (Nmn) Market Size Growth Rate By Application
1.3.2 Health Care Products
1.3.3 Cosmetics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Beta-nicotinamide Mononucleotide (Nmn) Sales Estimates And Forecasts 2017-2028
2.2 Global Beta-nicotinamide Mononucleotide (Nmn) Revenue Estimates And Forecasts 2017-2028
2.3 Global Beta-nicotinamide Mononucleotide (Nmn) Revenue By Region: 2017 Vs 2022 Vs 2028
2.4 Global Top Beta-nicotinamide Mononucleotide (Nmn) Regions By Sales
2.4.1 Global Top Beta-nicotinamide Mononucleotide (Nmn) Regions By Sales (2017-2022)
2.4.2 Global Top Beta-nicotinamide Mononucleotide (Nmn) Regions By Sales (2023-2028)
2.5 Global Top Beta-nicotinamide Mononucleotide (Nmn) Regions By Revenue
2.5.1 Global Top Beta-nicotinamide Mononucleotide (Nmn) Regions By Revenue (2017-2022)
2.5.2 Global Top Beta-nicotinamide Mononucleotide (Nmn) Regions By Revenue (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-pacific
2.9 Latin America
2.10 Middle East And Africa
3 Competition By Manufacturers
3.1 Global Beta-nicotinamide Mononucleotide (Nmn) Sales By Manufacturers
3.1.1 Global Top Beta-nicotinamide Mononucleotide (Nmn) Manufacturers By Sales (2017-2022)
3.1.2 Global Top Beta-nicotinamide Mononucleotide (Nmn) Manufacturers Market Share By Sales (2017-2022)
3.1.3 Global Top 5 Companies By Beta-nicotinamide Mononucleotide (Nmn) Sales In 2021
3.2 Global Beta-nicotinamide Mononucleotide (Nmn) Revenue By Manufacturers
3.2.1 Global Top Beta-nicotinamide Mononucleotide (Nmn) Manufacturers By Revenue (2017-2022)
3.2.2 Global Top Beta-nicotinamide Mononucleotide (Nmn) Manufacturers Market Share By Revenue (2017-2022)
3.2.3 Global Top 5 Companies By Beta-nicotinamide Mononucleotide (Nmn) Revenue In 2021
3.3 Global Beta-nicotinamide Mononucleotide (Nmn) Sales Price By Manufacturers
3.4 Analysis Of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (Cr5)
3.4.2 Global Beta-nicotinamide Mononucleotide (Nmn) Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
3.4.3 Global Beta-nicotinamide Mononucleotide (Nmn) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size By Type
4.1 Global Beta-nicotinamide Mononucleotide (Nmn) Sales By Type
4.1.1 Global Beta-nicotinamide Mononucleotide (Nmn) Historical Sales By Type (2017-2022)
4.1.2 Global Beta-nicotinamide Mononucleotide (Nmn) Forecasted Sales By Type (2023-2028)
4.1.3 Global Beta-nicotinamide Mononucleotide (Nmn) Sales Market Share By Type (2017-2028)
4.2 Global Beta-nicotinamide Mononucleotide (Nmn) Revenue By Type
4.2.1 Global Beta-nicotinamide Mononucleotide (Nmn) Historical Revenue By Type (2017-2022)
4.2.2 Global Beta-nicotinamide Mononucleotide (Nmn) Forecasted Revenue By Type (2023-2028)
4.2.3 Global Beta-nicotinamide Mononucleotide (Nmn) Revenue Market Share By Type (2017-2028)
4.3 Global Beta-nicotinamide Mononucleotide (Nmn) Price By Type
4.3.1 Global Beta-nicotinamide Mononucleotide (Nmn) Price By Type (2017-2022)
4.3.2 Global Beta-nicotinamide Mononucleotide (Nmn) Price Forecast By Type (2023-2028)
5 Market Size By Application
5.1 Global Beta-nicotinamide Mononucleotide (Nmn) Sales By Application
5.1.1 Global Beta-nicotinamide Mononucleotide (Nmn) Historical Sales By Application (2017-2022)
5.1.2 Global Beta-nicotinamide Mononucleotide (Nmn) Forecasted Sales By Application (2023-2028)
5.1.3 Global Beta-nicotinamide Mononucleotide (Nmn) Sales Market Share By Application (2017-2028)
5.2 Global Beta-nicotinamide Mononucleotide (Nmn) Revenue By Application
5.2.1 Global Beta-nicotinamide Mononucleotide (Nmn) Historical Revenue By Application (2017-2022)
5.2.2 Global Beta-nicotinamide Mononucleotide (Nmn) Forecasted Revenue By Application (2023-2028)
5.2.3 Global Beta-nicotinamide Mononucleotide (Nmn) Revenue Market Share By Application (2017-2028)
5.3 Global Beta-nicotinamide Mononucleotide (Nmn) Price By Application
5.3.1 Global Beta-nicotinamide Mononucleotide (Nmn) Price By Application (2017-2022)
5.3.2 Global Beta-nicotinamide Mononucleotide (Nmn) Price Forecast By Application (2023-2028)
6 North America
6.1 North America Beta-nicotinamide Mononucleotide (Nmn) Market Size By Type
6.1.1 North America Beta-nicotinamide Mononucleotide (Nmn) Sales By Type (2017-2028)
6.1.2 North America Beta-nicotinamide Mononucleotide (Nmn) Revenue By Type (2017-2028)
6.2 North America Beta-nicotinamide Mononucleotide (Nmn) Market Size By Application
6.2.1 North America Beta-nicotinamide Mononucleotide (Nmn) Sales By Application (2017-2028)
6.2.2 North America Beta-nicotinamide Mononucleotide (Nmn) Revenue By Application (2017-2028)
6.3 North America Beta-nicotinamide Mononucleotide (Nmn) Market Size By Country
6.3.1 North America Beta-nicotinamide Mononucleotide (Nmn) Sales By Country (2017-2028)
6.3.2 North America Beta-nicotinamide Mononucleotide (Nmn) Revenue By Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Beta-nicotinamide Mononucleotide (Nmn) Market Size By Type
7.1.1 Europe Beta-nicotinamide Mononucleotide (Nmn) Sales By Type (2017-2028)
7.1.2 Europe Beta-nicotinamide Mononucleotide (Nmn) Revenue By Type (2017-2028)
7.2 Europe Beta-nicotinamide Mononucleotide (Nmn) Market Size By Application
7.2.1 Europe Beta-nicotinamide Mononucleotide (Nmn) Sales By Application (2017-2028)
7.2.2 Europe Beta-nicotinamide Mononucleotide (Nmn) Revenue By Application (2017-2028)
7.3 Europe Beta-nicotinamide Mononucleotide (Nmn) Market Size By Country
7.3.1 Europe Beta-nicotinamide Mononucleotide (Nmn) Sales By Country (2017-2028)
7.3.2 Europe Beta-nicotinamide Mononucleotide (Nmn) Revenue By Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Beta-nicotinamide Mononucleotide (Nmn) Market Size By Type
8.1.1 Asia Pacific Beta-nicotinamide Mononucleotide (Nmn) Sales By Type (2017-2028)
8.1.2 Asia Pacific Beta-nicotinamide Mononucleotide (Nmn) Revenue By Type (2017-2028)
8.2 Asia Pacific Beta-nicotinamide Mononucleotide (Nmn) Market Size By Application
8.2.1 Asia Pacific Beta-nicotinamide Mononucleotide (Nmn) Sales By Application (2017-2028)
8.2.2 Asia Pacific Beta-nicotinamide Mononucleotide (Nmn) Revenue By Application (2017-2028)
8.3 Asia Pacific Beta-nicotinamide Mononucleotide (Nmn) Market Size By Region
8.3.1 Asia Pacific Beta-nicotinamide Mononucleotide (Nmn) Sales By Region (2017-2028)
8.3.2 Asia Pacific Beta-nicotinamide Mononucleotide (Nmn) Revenue By Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 Korea
8.3.6 India
8.3.7 Australia
8.3.8 Southeast Asia
9 Latin America
9.1 Latin America Beta-nicotinamide Mononucleotide (Nmn) Market Size By Type
9.1.1 Latin America Beta-nicotinamide Mononucleotide (Nmn) Sales By Type (2017-2028)
9.1.2 Latin America Beta-nicotinamide Mononucleotide (Nmn) Revenue By Type (2017-2028)
9.2 Latin America Beta-nicotinamide Mononucleotide (Nmn) Market Size By Application
9.2.1 Latin America Beta-nicotinamide Mononucleotide (Nmn) Sales By Application (2017-2028)
9.2.2 Latin America Beta-nicotinamide Mononucleotide (Nmn) Revenue By Application (2017-2028)
9.3 Latin America Beta-nicotinamide Mononucleotide (Nmn) Market Size By Country
9.3.1 Latin America Beta-nicotinamide Mononucleotide (Nmn) Sales By Country (2017-2028)
9.3.2 Latin America Beta-nicotinamide Mononucleotide (Nmn) Revenue By Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East And Africa
10.1 Middle East And Africa Beta-nicotinamide Mononucleotide (Nmn) Market Size By Type
10.1.1 Middle East And Africa Beta-nicotinamide Mononucleotide (Nmn) Sales By Type (2017-2028)
10.1.2 Middle East And Africa Beta-nicotinamide Mononucleotide (Nmn) Revenue By Type (2017-2028)
10.2 Middle East And Africa Beta-nicotinamide Mononucleotide (Nmn) Market Size By Application
10.2.1 Middle East And Africa Beta-nicotinamide Mononucleotide (Nmn) Sales By Application (2017-2028)
10.2.2 Middle East And Africa Beta-nicotinamide Mononucleotide (Nmn) Revenue By Application (2017-2028)
10.3 Middle East And Africa Beta-nicotinamide Mononucleotide (Nmn) Market Size By Country
10.3.1 Middle East And Africa Beta-nicotinamide Mononucleotide (Nmn) Sales By Country (2017-2028)
10.3.2 Middle East And Africa Beta-nicotinamide Mononucleotide (Nmn) Revenue By Country (2017-2028)
10.3.3 Middle East
10.3.4 Africa
11 Corporate Profile
11.1 Geneharbor
11.1.1 Geneharbor Corporation Information
11.1.2 Geneharbor Overview
11.1.3 Geneharbor Beta-nicotinamide Mononucleotide (Nmn) Sales, Price, Revenue And Gross Margin (2017-2022)
11.1.4 Geneharbor Beta-nicotinamide Mononucleotide (Nmn) Product Model Numbers, Pictures, Descriptions And Specifications
11.1.5 Geneharbor Recent Developments
11.2 Herbalmax
11.2.1 Herbalmax Corporation Information
11.2.2 Herbalmax Overview
11.2.3 Herbalmax Beta-nicotinamide Mononucleotide (Nmn) Sales, Price, Revenue And Gross Margin (2017-2022)
11.2.4 Herbalmax Beta-nicotinamide Mononucleotide (Nmn) Product Model Numbers, Pictures, Descriptions And Specifications
11.3 Genex Formulas
11.3.1 Genex Formulas Corporation Information
11.3.2 Genex Formulas Overview
11.3.3 Genex Formulas Beta-nicotinamide Mononucleotide (Nmn) Sales, Price, Revenue And Gross Margin (2017-2022)
11.3.4 Genex Formulas Beta-nicotinamide Mononucleotide (Nmn) Product Model Numbers, Pictures, Descriptions And Specifications
11.4 Shinkowa Pharmaceutical
11.4.1 Shinkowa Pharmaceutical Corporation Information
11.4.2 Shinkowa Pharmaceutical Overview
11.4.3 Shinkowa Pharmaceutical Beta-nicotinamide Mononucleotide (Nmn) Sales, Price, Revenue And Gross Margin (2017-2022)
11.4.4 Shinkowa Pharmaceutical Beta-nicotinamide Mononucleotide (Nmn) Product Model Numbers, Pictures, Descriptions And Specifications
11.4.5 Shinkowa Pharmaceutical Recent Developments
11.5 Maac10 Formulas
11.5.1 Maac10 Formulas Corporation Information
11.5.2 Maac10 Formulas Overview
11.5.3 Maac10 Formulas Beta-nicotinamide Mononucleotide (Nmn) Sales, Price, Revenue And Gross Margin (2017-2022)
11.5.4 Maac10 Formulas Beta-nicotinamide Mononucleotide (Nmn) Product Model Numbers, Pictures, Descriptions And Specifications
11.6 Effepharm
11.6.1 Effepharm Corporation Information
11.6.2 Effepharm Overview
11.6.3 Effepharm Beta-nicotinamide Mononucleotide (Nmn) Sales, Price, Revenue And Gross Margin (2017-2022)
11.6.4 Effepharm Beta-nicotinamide Mononucleotide (Nmn) Product Model Numbers, Pictures, Descriptions And Specifications
11.7 Bontac
11.7.1 Bontac Corporation Information
11.7.2 Bontac Overview
11.7.3 Bontac Beta-nicotinamide Mononucleotide (Nmn) Sales, Price, Revenue And Gross Margin (2017-2022)
11.7.4 Bontac Beta-nicotinamide Mononucleotide (Nmn) Product Model Numbers, Pictures, Descriptions And Specifications
11.7.5 Bontac Recent Developments
11.8 Celfull
11.8.1 Celfull Corporation Information
11.8.2 Celfull Overview
11.8.3 Celfull Beta-nicotinamide Mononucleotide (Nmn) Sales, Price, Revenue And Gross Margin (2017-2022)
11.8.4 Celfull Beta-nicotinamide Mononucleotide (Nmn) Product Model Numbers, Pictures, Descriptions And Specifications
11.9 Kingdomway
11.9.1 Kingdomway Corporation Information
11.9.2 Kingdomway Overview
11.9.3 Kingdomway Beta-nicotinamide Mononucleotide (Nmn) Sales, Price, Revenue And Gross Margin (2017-2022)
11.9.4 Kingdomway Beta-nicotinamide Mononucleotide (Nmn) Product Model Numbers, Pictures, Descriptions And Specifications
12 Value Chain And Sales Channels Analysis
12.1 Beta-nicotinamide Mononucleotide (Nmn) Value Chain Analysis
12.2 Beta-nicotinamide Mononucleotide (Nmn) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Beta-nicotinamide Mononucleotide (Nmn) Production Mode & Process
12.4 Beta-nicotinamide Mononucleotide (Nmn) Sales And Marketing
12.4.1 Beta-nicotinamide Mononucleotide (Nmn) Sales Channels
12.4.2 Beta-nicotinamide Mononucleotide (Nmn) Distributors
12.5 Beta-nicotinamide Mononucleotide (Nmn) Customers
13 Market Drivers, Opportunities, Challenges And Risks Factors Analysis
13.1 Beta-nicotinamide Mononucleotide (Nmn) Industry Trends
13.2 Beta-nicotinamide Mononucleotide (Nmn) Market Drivers
13.3 Beta-nicotinamide Mononucleotide (Nmn) Market Challenges
13.4 Beta-nicotinamide Mononucleotide (Nmn) Market Restraints
14 Key Findings In The Global Beta-nicotinamide Mononucleotide (Nmn) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List Of Tables
Table 1. Global Beta-nicotinamide Mononucleotide (Nmn) Market Size Growth Rate By Type, 2017 Vs 2021 Vs 2028 (Us$ Million)
Table 2. Global Beta-nicotinamide Mononucleotide (Nmn) Market Size Growth Rate By Application, 2017 Vs 2021 Vs 2028 (Us$ Million)
Table 3. Global Beta-nicotinamide Mononucleotide (Nmn) Revenue By Region: 2017 Vs 2022 Vs 2028 (Us$ Million)
Table 4. Global Beta-nicotinamide Mononucleotide (Nmn) Sales By Region (2017-2022) & (Kg)
Table 5. Global Beta-nicotinamide Mononucleotide (Nmn) Sales Market Share By Region (2017-2022)
Table 6. Global Beta-nicotinamide Mononucleotide (Nmn) Sales By Region (2023-2028) & (Kg)
Table 7. Global Beta-nicotinamide Mononucleotide (Nmn) Sales Market Share By Region (2023-2028)
Table 8. Global Beta-nicotinamide Mononucleotide (Nmn) Sales Market Share By Region (2023-2028)
Table 9. Global Beta-nicotinamide Mononucleotide (Nmn) Revenue By Region (2017-2022) & (Us$ Million)
Table 10. Global Beta-nicotinamide Mononucleotide (Nmn) Revenue Market Share By Region (2017-2022)
Table 11. Global Beta-nicotinamide Mononucleotide (Nmn) Revenue By Region (2023-2028) & (Us$ Million)
Table 12. Global Beta-nicotinamide Mononucleotide (Nmn) Revenue Market Share By Region (2023-2028)
Table 13. Global Beta-nicotinamide Mononucleotide (Nmn) Sales By Manufacturers (2017-2022) & (Kg)
Table 14. Global Beta-nicotinamide Mononucleotide (Nmn) Sales Share By Manufacturers (2017-2022)
Table 15. Global Beta-nicotinamide Mononucleotide (Nmn) Revenue By Manufacturers (2017-2022) & (Us$ Million)
Table 16. Global Beta-nicotinamide Mononucleotide (Nmn) Revenue Share By Manufacturers (2017-2022)
Table 17. Beta-nicotinamide Mononucleotide (Nmn) Price By Manufacturers 2017-2022 (Usd/Kg)
Table 18. Global Beta-nicotinamide Mononucleotide (Nmn) Manufacturers Market Concentration Ratio (Cr5)
Table 19. Global Beta-nicotinamide Mononucleotide (Nmn) By Company Type (Tier 1, Tier 2, And Tier 3) & (Based On The Revenue In Beta-nicotinamide Mononucleotide (Nmn) As Of 2021)
Table 20. Beta-nicotinamide Mononucleotide (Nmn) Manufacturing Base Distribution And Headquarters

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us